Company profile
Fast and convenient diagnostic solutions | binx health
Binx Health Limited is a UK company with status active founded in 2005 based in South West England.
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
MA | Transaction MzQ0MTI0MDU5MmFkaXF6a2N4 | Paper/PDF filed
Published 31 Oct 2024 07:27
RESOLUTIONS | Transaction QUREWE1BUFRhZGlxemtjeA | Paper/PDF filed
Published 31 Oct 2024 07:25
RESOLUTIONS | Transaction QUREWE1BUTlhZGlxemtjeA | Paper/PDF filed
Published 28 Oct 2024 06:42
SH01 | Transaction MzQ0MDg1NzAxOGFkaXF6a2N4
Published 24 Oct 2024 03:14
AA | Transaction MzQ0MDA0MTYyN2FkaXF6a2N4 | Paper/PDF filed
Published 19 Oct 2024 06:36
SH01 | Transaction MzQzNjIzNjY2MmFkaXF6a2N4
Published 17 Sep 2024 19:16
Company registered at Companies House
1 Jun 2017 to 31 Mar 2020
A rapid stratified medicine diagnostic test for STI patients at the point-of-care. Atlas Genetics are developing a rapid, multi-pathogen, point-of-care (POC) diagnostic test for patients presenting at sexual health clinics, to enable the stratification of these patients, allowing sexual health professionals to direct immediate and effective treatment base...
1 Mar 2016 to 30 Nov 2016
A Rapid Stratified Medicine Diagnostic Test To Direct Treatment For Symptomatic Patients Presenting In Sexual Health Clinics Atlas Genetics will develop a rapid point-of-care (PoC) stratified medicine diagnostic (SMD) for patients presenting to Sexual Health Clinics with genital discharge syndrome, to allow immediate and accurate selection of appropriate ...
1 Jul 2012 to 31 Dec 2014
Diagnosis of SIRS & sepsis and identification of patients likely to progress to severe sepsis or septic shock is challenging due to a lack of definitive diagnostic tests. This project aims to identify biomarker panels for diagnosis and prognosis of SIRS, sepsis and likely progression to severe sepsis from patient host biomarkers identified in previously p...
1 Nov 2010 to 31 May 2015
This project is to develop a system for ultra-rapid and highly sensitive, DNA-based Point-Of-Care tests for Chlamydia and gonorrhoea. The system will use a disposable cartridge for testing a patient sample which will be processed using a low cost reader instrument. The system will have innovative features ensuring ease of use & accuracy which include: • a...
